Skip to main navigation
Skip to search
Skip to main content
Texas Tech University Scholars Home
Home
Scholars
Organizations
Grants
Research
Scholarly Activities
Search by expertise, name or affiliation
Cytotoxicity of selenium trastuzumab and bevacizumab immunoconjugates against triple negative breast cancer cells
Julian Spallholz (Speaker)
Nutritional Sciences
Activity
:
Talk or presentation
›
Other
Period
Apr 1 2017
→
Apr 30 2017
Held at
American Association for Cancer Reserach
Degree of Recognition
International